Assignee
TRACON PHARMACEUTICALS INC
US·8 granted patents·8 pending applications·58 citations·filing 2007–2019
Top patents by PatentIndex Score
16 records- 0194US9926375B2Anti-endoglin antibodies and uses thereofTRACON PHARMACEUTICALS INC·Filed 2016·Granted Mar 27, 2018·15 cites·16 claims
- 0293US9150652B2Endoglin antibodiesTRACON PHARMACEUTICALS INC·Filed 2013·Granted Oct 6, 2015·18 cites·24 claims
- 0391US9944714B2Endoglin antibodiesTRACON PHARMACEUTICALS INC·Filed 2016·Granted Apr 17, 2018·7 cites·29 claims
- 0488US10336831B2Use of anti-endoglin antibodies for treating ocular fibrosisTRACON PHARMACEUTICALS INC·Filed 2018·Granted Jul 2, 2019·6 cites·20 claims
- 0588US9518122B2Endoglin antibodiesTRACON PHARMACEUTICALS INC·Filed 2015·Granted Dec 13, 2016·5 cites·24 claims
- 0687US10155820B2Anti-endoglin antibodies and uses thereofTRACON PHARMACEUTICALS INC·Filed 2015·Granted Dec 18, 2018·6 cites·22 claims
- 0769US10195281B2Antibody formulations and uses thereofTRACON PHARMACEUTICALS INC·Filed 2013·Granted Feb 5, 2019·1 cites·36 claims
- 0869US2020048360A1Endoglin AntibodiesTRACON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0965US2018194854A1Endoglin AntibodiesTRACON PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1058US2020087389A1Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agentsTRACON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1157US8017618B2Antifolate agent combinations in the treatment of cancerTRACON PHARMACEUTICALS INC·Filed 2007·Granted Sep 13, 2011·0 cites·36 claims
- 1256US2019016815A1Anti-endoglin antibodies and uses thereofTRACON PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1355US2018371072A1Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agentsTRACON PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1455US2017312233A1Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitorsTRACON PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1549US2018311359A1Antibody Formulations and Uses ThereofTRACON PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1643US2018057602A1Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agentsTRACON PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TRACON PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →